Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of SHR-1918 in patients with hyperlipidemia and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• SHR-1918

Snippet

Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd | Conditions: Hyperlipidemia | Phase 3 | Status: RECRUITING